175 related articles for article (PubMed ID: 22895861)
1. Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model.
Vandeputte C; Casteels C; Struys T; Koole M; van Veghel D; Evens N; Gerits A; Dresselaers T; Lambrichts I; Himmelreich U; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1796-806. PubMed ID: 22895861
[TBL] [Abstract][Full Text] [Related]
2. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.
Evens N; Vandeputte C; Coolen C; Janssen P; Sciot R; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Nucl Med Biol; 2012 Apr; 39(3):389-99. PubMed ID: 22154685
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
5. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
[TBL] [Abstract][Full Text] [Related]
6. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.
Fan Y; Hooker BA; Garrison TR; El-Kouhen OF; Idler KB; Holley-Shanks RR; Meyer MD; Yao BB
Eur J Pharmacol; 2011 Jun; 659(2-3):161-8. PubMed ID: 21458448
[TBL] [Abstract][Full Text] [Related]
9. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.
Casteels C; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1164-73. PubMed ID: 20182714
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
[TBL] [Abstract][Full Text] [Related]
11. Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.
Casteels C; Martinez E; Bormans G; Camon L; de Vera N; Baekelandt V; Planas AM; Van Laere K
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2354-63. PubMed ID: 20680268
[TBL] [Abstract][Full Text] [Related]
12. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
Casteels C; Lauwers E; Baitar A; Bormans G; Baekelandt V; Van Laere K
Brain Res; 2010 Feb; 1316():153-62. PubMed ID: 20026090
[TBL] [Abstract][Full Text] [Related]
13. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats.
Suárez J; Llorente R; Romero-Zerbo SY; Mateos B; Bermúdez-Silva FJ; de Fonseca FR; Viveros MP
Hippocampus; 2009 Jul; 19(7):623-32. PubMed ID: 19115376
[TBL] [Abstract][Full Text] [Related]
14. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
[TBL] [Abstract][Full Text] [Related]
16. Whole-body biodistribution of the cannabinoid type 1 receptor ligand [
Buchholz HG; Uebbing K; Maus S; Pektor S; Afahaene N; Weyer-Elberich V; Lutz B; Schreckenberger M; Miederer I
Nucl Med Biol; 2017 Sep; 52():63-69. PubMed ID: 28648984
[TBL] [Abstract][Full Text] [Related]
17. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
Hamill TG; Lin LS; Hagmann W; Liu P; Jewell J; Sanabria S; Eng W; Ryan C; Fong TM; Connolly B; Vanko A; Hargreaves R; Goulet MT; Burns HD
Mol Imaging Biol; 2009; 11(4):246-52. PubMed ID: 19130142
[TBL] [Abstract][Full Text] [Related]
18. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.
Casteels C; Gérard N; van Kuyck K; Pottel L; Nuttin B; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):308-21. PubMed ID: 24006151
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
